• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adverse events associated with intravenous fosfomycin.

作者信息

Florent Amélie, Chichmanian Rose-Marie, Cua Eric, Pulcini Céline

出版信息

Int J Antimicrob Agents. 2011 Jan;37(1):82-3. doi: 10.1016/j.ijantimicag.2010.09.002. Epub 2010 Nov 11.

DOI:10.1016/j.ijantimicag.2010.09.002
PMID:21074377
Abstract
摘要

相似文献

1
Adverse events associated with intravenous fosfomycin.
Int J Antimicrob Agents. 2011 Jan;37(1):82-3. doi: 10.1016/j.ijantimicag.2010.09.002. Epub 2010 Nov 11.
2
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.静脉注射磷霉素治疗重症患者耐碳青霉烯类肺炎克雷伯菌引起的医院感染：前瞻性评估。
Clin Microbiol Infect. 2010 Feb;16(2):184-6. doi: 10.1111/j.1469-0691.2009.02921.x. Epub 2009 Aug 20.
3
[Monural--new antibiotic with single intake for treatment of acute cystitis].[莫努拉尔——单次服用治疗急性膀胱炎的新型抗生素]
Akush Ginekol (Sofiia). 2008;47(4):56.
4
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.磷霉素治疗全身感染患者的药代动力学和药效学特征的临床意义。
Int J Antimicrob Agents. 2009 Dec;34(6):506-15. doi: 10.1016/j.ijantimicag.2009.08.013. Epub 2009 Oct 13.
5
Monitoring of high-dose fosfomycin guided by NT-proBNP.N末端B型利钠肽原（NT-proBNP）引导下的高剂量磷霉素监测
Int J Cardiol. 2016 Apr 15;209:131-2. doi: 10.1016/j.ijcard.2016.02.037. Epub 2016 Feb 3.
6
Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?大剂量静脉注射磷霉素治疗易发生心力衰竭的患者是否安全？
Enferm Infecc Microbiol Clin. 2015 Apr;33(4):294. doi: 10.1016/j.eimc.2014.07.005. Epub 2014 Oct 23.
7
Extracellular concentrations of fosfomycin in lung tissue of septic patients.脓毒症患者肺组织中磷霉素的细胞外浓度。
J Antimicrob Chemother. 2010 May;65(5):995-8. doi: 10.1093/jac/dkq070. Epub 2010 Mar 12.
8
[Fosfomycin in the treatment of some infectious diseases].
Clin Ter. 1979 Jan 15;88(1):61-6.
9
Acute renal insufficiency in cats after fosfomycin administration.
Vet Rec. 2008 Sep 13;163(11):337-8. doi: 10.1136/vr.163.11.337.
10
Intravenous fosfomycin-back to the future. Systematic review and meta-analysis of the clinical literature.静脉注射磷霉素——回到未来。临床文献的系统评价和荟萃分析。
Clin Microbiol Infect. 2017 Jun;23(6):363-372. doi: 10.1016/j.cmi.2016.12.005. Epub 2016 Dec 9.

引用本文的文献

1
Efficacy and Safety of Fosfomycin Disodium in Patients with Bacterial Infections: A Single-Center, Real-Life Clinical Study.磷霉素钠治疗细菌感染患者的疗效与安全性：一项单中心、真实临床研究
J Clin Med. 2025 Jun 19;14(12):4386. doi: 10.3390/jcm14124386.
2
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study.监测静脉注射磷霉素的血药浓度以预防药物相关不良事件：一项回顾性观察研究。
Antibiotics (Basel). 2025 May 27;14(6):548. doi: 10.3390/antibiotics14060548.
3
Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review.
静脉注射磷霉素治疗生物膜相关骨与关节感染的新观念：文献综述
Microorganisms. 2025 Apr 23;13(5):963. doi: 10.3390/microorganisms13050963.
4
Intravenous Fosfomycin for Difficult-to-Treat Infections: A Real-Life Multicentric Study in Italy.静脉注射磷霉素治疗难治性感染：意大利一项真实世界多中心研究
Antibiotics (Basel). 2025 Apr 14;14(4):401. doi: 10.3390/antibiotics14040401.
5
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study.静脉注射磷霉素的真实世界应用、有效性及安全性：FORTRESS研究
Infect Dis Ther. 2025 Apr;14(4):765-791. doi: 10.1007/s40121-025-01125-2. Epub 2025 Mar 19.
6
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Infections?当与大剂量达托霉素联合用于治疗感染时，持续输注8克磷霉素的减量剂量是否可被认为与标准的16克剂量一样有效且更安全？
Antibiotics (Basel). 2025 Feb 1;14(2):139. doi: 10.3390/antibiotics14020139.
7
Optimized fosfomycin regimens for treating carbapenem-resistant Acinetobacter baumannii in critically ill patients with varying degrees of renal function.优化的磷霉素方案治疗不同肾功能严重程度的危重症患者耐碳青霉烯鲍曼不动杆菌。
Clin Transl Sci. 2024 Oct;17(10):e70038. doi: 10.1111/cts.70038.
8
The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.磷霉素对革兰氏阴性菌感染的影响：一项全面综述。
Indian J Microbiol. 2024 Sep;64(3):846-858. doi: 10.1007/s12088-024-01293-8. Epub 2024 May 7.
9
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review.了解重症患者的抗菌药物药代动力学以优化抗菌治疗：一篇叙述性综述。
J Intensive Med. 2024 Feb 29;4(3):287-298. doi: 10.1016/j.jointm.2023.12.007. eCollection 2024 Jul.
10
Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring.真实场景下静脉注射磷霉素治疗期间的不良事件。危险因素和治疗药物监测的潜在作用。
BMC Infect Dis. 2024 Jun 28;24(1):650. doi: 10.1186/s12879-024-09541-4.